ZNF419 and cancer: To elucidate the role of ZNF419 across cancers from the perspective of gene mutation, we divided patients into two groups according to the ZNF419 expression levels in each type of cancer with relatively high mutation rates (PRAD, KIRC, LIHC, BLCA, and LUSC), and observed similarities and differences in gene mutation conditions between the two groups.